• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肌肉阻滞模拟中效应室的容积。

Volume of the effect compartment in simulations of neuromuscular block.

作者信息

Nigrovic Vladimir, Proost Johannes H, Amann Anton, Bhatt Shashi B

机构信息

Department of Anesthesiology, Medical University of Ohio, Toledo, OH, USA.

出版信息

Theor Biol Med Model. 2005 Oct 3;2:41. doi: 10.1186/1742-4682-2-41.

DOI:10.1186/1742-4682-2-41
PMID:16202142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1262782/
Abstract

BACKGROUND

The study examines the role of the volume of the effect compartment in simulations of neuromuscular block (NMB) produced by nondepolarizing muscle relaxants.

METHODS

The molar amount of the postsynaptic receptors at the motor end plates in muscle was assumed constant; the apparent receptor concentration in the effect compartment is the ratio of this amount and the volume arbitrarily assigned to the effect compartment. The muscle relaxants were postulated to diffuse between the central and the effect compartment and to bind to the postsynaptic receptors. NMB was calculated from the free concentration of the muscle relaxant in the effect compartment.

RESULTS

The simulations suggest that the time profiles of NMB and the derived pharmacokinetic and pharmacodynamic variables are dependent on the apparent receptor concentration in the effect compartment. For small, but not for large, volumes, times to peak submaximal NMB are projected to depend on the magnitude of NMB and on the binding affinities.

CONCLUSION

An experimental design to estimate the volume of the effect compartment is suggested.

摘要

背景

本研究探讨效应室容积在非去极化肌松药产生的神经肌肉阻滞(NMB)模拟中的作用。

方法

假设肌肉运动终板处突触后受体的摩尔量恒定;效应室中表观受体浓度为此量与任意指定给效应室的容积之比。假定肌松药在中央室和效应室之间扩散并与突触后受体结合。NMB由效应室中肌松药的游离浓度计算得出。

结果

模拟结果表明,NMB的时间曲线以及推导的药代动力学和药效学变量取决于效应室中的表观受体浓度。对于小容积而非大容积,次最大NMB峰值时间预计取决于NMB的大小和结合亲和力。

结论

提出了一种估计效应室容积的实验设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/ff2fe4ecfc7d/1742-4682-2-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/00c708d82352/1742-4682-2-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/be03be0d6dde/1742-4682-2-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/91035afa3578/1742-4682-2-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/ff2fe4ecfc7d/1742-4682-2-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/00c708d82352/1742-4682-2-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/be03be0d6dde/1742-4682-2-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/91035afa3578/1742-4682-2-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a00/1262782/ff2fe4ecfc7d/1742-4682-2-41-4.jpg

相似文献

1
Volume of the effect compartment in simulations of neuromuscular block.神经肌肉阻滞模拟中效应室的容积。
Theor Biol Med Model. 2005 Oct 3;2:41. doi: 10.1186/1742-4682-2-41.
2
Analysis of the pharmacodynamic parameters in a model for neuromuscular block.
Med Sci Monit. 2004 Dec;10(12):BR468-76.
3
Competition between acetylcholine and a nondepolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block.乙酰胆碱与非去极化肌松药在运动终板处竞争结合突触后受体:单收缩强度及神经肌肉阻滞的模拟
J Pharmacokinet Pharmacodyn. 2003 Feb;30(1):23-51. doi: 10.1023/a:1023245409315.
4
Onset-potency relationship of nondepolarizing muscle relaxants: a reexamination using simulations.非去极化肌松药的起效-效能关系:使用模拟进行的重新审视
Can J Physiol Pharmacol. 2007 Aug;85(8):774-82. doi: 10.1139/y07-072.
5
Onset of the neuromuscular block simulated in an anatomical model.
Br J Clin Pharmacol. 1997 Jan;43(1):55-63. doi: 10.1111/j.1365-2125.1997.tb00033.x.
6
Simulation of interaction between two non-depolarizing muscle relaxants: generation of an additive or a supra-additive neuromuscular block.两种非去极化肌松药相互作用的模拟:相加或超相加神经肌肉阻滞的产生
J Pharmacokinet Pharmacodyn. 2004 Apr;31(2):157-79. doi: 10.1023/b:jopa.0000034406.00667.20.
7
Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis.神经肌肉阻滞希尔方程中常数的生理药理学解释:一种假说
J Pharmacokinet Pharmacodyn. 2002 Apr;29(2):189-206. doi: 10.1023/a:1019759725394.
8
Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.腰椎间盘手术中给予插管剂量的顺式阿曲库铵和罗库溴铵后神经肌肉阻滞的恢复情况。
Acta Anaesthesiol Belg. 2004;55(2):129-33.
9
Simulation of the kinetics of neuromuscular block: implications for speed of onset.神经肌肉阻滞动力学模拟:对起效速度的影响。
Anesth Analg. 2013 Oct;117(4):792-802. doi: 10.1213/ANE.0b013e31827ee17f. Epub 2013 Mar 1.
10
Simulation of the reversal of neuromuscular block by sequestration of the free molecules of the muscle relaxant.通过隔离肌肉松弛剂的游离分子模拟神经肌肉阻滞的逆转。
J Pharmacokinet Pharmacodyn. 2007 Dec;34(6):771-88. doi: 10.1007/s10928-007-9068-y. Epub 2007 Sep 21.

引用本文的文献

1
Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.基于非去极化肌松药与突触前受体的缓慢相互作用对颤搐衰减的建模。
J Pharmacokinet Pharmacodyn. 2006 Aug;33(4):461-83. doi: 10.1007/s10928-006-9017-1. Epub 2006 Jun 3.

本文引用的文献

1
The relationship between the mode of operation and the dimensions of the junctional regions at synapses and motor end-organs.突触和运动终末器官处的连接区域的运作模式与尺寸之间的关系。
Proc R Soc Lond B Biol Sci. 1958 Jan 1;148(930):38-56. doi: 10.1098/rspb.1958.0003.
2
Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.在重症肌无力患者中,通过考虑未结合的乙酰胆碱受体数量,可改善罗库溴铵的药代动力学/药效学模型。
Anesth Analg. 2002 Sep;95(3):588-96, table of contents. doi: 10.1097/00000539-200209000-00018.
3
Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
外周链接模型作为消除半衰期极短药物的药代动力学-药效学建模的替代方法。
J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):7-25. doi: 10.1023/a:1011513618081.
4
Pharmacodynamic modeling of vecuronium-induced twitch depression. Rapid plasma-effect site equilibration explains faster onset at resistant laryngeal muscles than at the adductor pollicis.维库溴铵诱导的抽搐抑制的药效学模型。快速的血浆-效应部位平衡解释了其在抗药的喉部肌肉中起效比在拇内收肌中更快的原因。
Anesthesiology. 1997 Mar;86(3):558-66. doi: 10.1097/00000542-199703000-00007.
5
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.一个扩展的药代动力学/药效学模型,用于定量描述血浆蛋白结合、组织结合和受体结合对药物效力和作用时间过程的影响。
J Pharmacokinet Biopharm. 1996 Feb;24(1):45-77. doi: 10.1007/BF02353510.
6
Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.重症肌无力中的神经肌肉接头:乙酰胆碱受体减少。
Science. 1973 Oct 19;182(4109):293-5. doi: 10.1126/science.182.4109.293.
7
Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.重症肌无力中连接性乙酰胆碱受体的测量:临床相关性
Muscle Nerve. 1985 Mar-Apr;8(3):245-51. doi: 10.1002/mus.880080311.
8
Atracurium-receptor kinetics: simple behavior from a mixture.阿曲库铵-受体动力学:混合物的简单行为
Anesth Analg. 1985 Aug;64(8):777-80.
9
A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.一种用于解释神经肌肉阻滞药物高效能与起效时间缓慢之间关系的动力学-动态模型。
J Pharmacokinet Biopharm. 1991 Oct;19(5):537-52. doi: 10.1007/BF01062962.
10
Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.药代动力学和药效学的同步建模:应用于筒箭毒碱。
Clin Pharmacol Ther. 1979 Mar;25(3):358-71. doi: 10.1002/cpt1979253358.